(1)
Ahmud, M. W.; Mustafa, M.; Asim, W. A Rare Disease Gets a Breakthrough: Ctexli Approved for Cerebrotendinous Xanthomatosis. Int J Basic Clin Pharmacol 2025, 14, 649-650.